BARINTHUS BIOTHERAPEUTICS PLC: interest paid, net
Interest paid, net for BARINTHUS BIOTHERAPEUTICS PLC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All BARINTHUS BIOTHERAPEUTICS PLC financial histories
What this measure means
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
Exact concept: us-gaap:InterestPaidNet. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2020-01-01 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2023-01-01 | 2023-12-31 | 0 | USD | 2024-03-20 | 10-K · 0001828185-24-000011 |
| 2022-01-01 | 2022-12-31 | 0 | USD | 2024-03-20 | 10-K · 0001828185-24-000011 |
| 2021-01-01 | 2021-12-31 | 1,844,000 | USD | 2023-03-24 | 10-K · 0001104659-23-036275 |
| 2020-01-01 | 2020-12-31 | 2,000 | USD | 2022-03-25 | 10-K · 0001104659-22-037794 |
Related financial histories
- BARINTHUS BIOTHERAPEUTICS PLC: total assets
- BARINTHUS BIOTHERAPEUTICS PLC: total liabilities
- BARINTHUS BIOTHERAPEUTICS PLC: stockholders equity
- BARINTHUS BIOTHERAPEUTICS PLC: cash and cash equivalents
- BARINTHUS BIOTHERAPEUTICS PLC: net income or loss
- BARINTHUS BIOTHERAPEUTICS PLC: operating cash flow
- BARINTHUS BIOTHERAPEUTICS PLC: capital expenditure payments
- BARINTHUS BIOTHERAPEUTICS PLC: contract revenue excluding tax
- BARINTHUS BIOTHERAPEUTICS PLC: financing cash flow
- BARINTHUS BIOTHERAPEUTICS PLC: investing cash flow
- BARINTHUS BIOTHERAPEUTICS PLC: retained earnings or deficit
- BARINTHUS BIOTHERAPEUTICS PLC: basic weighted-average shares
- BARINTHUS BIOTHERAPEUTICS PLC: diluted weighted-average shares
- BARINTHUS BIOTHERAPEUTICS PLC: basic earnings per share
- BARINTHUS BIOTHERAPEUTICS PLC: diluted earnings per share
- BARINTHUS BIOTHERAPEUTICS PLC: income tax expense or benefit
- BARINTHUS BIOTHERAPEUTICS PLC: net property, plant and equipment
- BARINTHUS BIOTHERAPEUTICS PLC: share-based compensation expense
- BARINTHUS BIOTHERAPEUTICS PLC: operating income or loss
- BARINTHUS BIOTHERAPEUTICS PLC: current assets
- BARINTHUS BIOTHERAPEUTICS PLC: interest expense
- BARINTHUS BIOTHERAPEUTICS PLC: current liabilities
- BARINTHUS BIOTHERAPEUTICS PLC: current accounts payable
- BARINTHUS BIOTHERAPEUTICS PLC: goodwill carrying amount
- BARINTHUS BIOTHERAPEUTICS PLC: net current accounts receivable
- BARINTHUS BIOTHERAPEUTICS PLC: operating expenses
- BARINTHUS BIOTHERAPEUTICS PLC: research and development expense
- BARINTHUS BIOTHERAPEUTICS PLC: common shares outstanding
- BARINTHUS BIOTHERAPEUTICS PLC: cash including restricted cash
- BARINTHUS BIOTHERAPEUTICS PLC: additional paid-in capital
- BARINTHUS BIOTHERAPEUTICS PLC: total equity including noncontrolling interests
- BARINTHUS BIOTHERAPEUTICS PLC: operating lease right-of-use asset
- BARINTHUS BIOTHERAPEUTICS PLC: operating lease liability
- BARINTHUS BIOTHERAPEUTICS PLC: gross property, plant and equipment
- BARINTHUS BIOTHERAPEUTICS PLC: accumulated depreciation on property, plant and equipment
- BARINTHUS BIOTHERAPEUTICS PLC: net intangible assets excluding goodwill
- BARINTHUS BIOTHERAPEUTICS PLC: other noncurrent liabilities
- BARINTHUS BIOTHERAPEUTICS PLC: prepaid expenses and other current assets
- BARINTHUS BIOTHERAPEUTICS PLC: net deferred tax assets
- BARINTHUS BIOTHERAPEUTICS PLC: net deferred tax liabilities
- BARINTHUS BIOTHERAPEUTICS PLC: pre-tax income or loss from continuing operations
- BARINTHUS BIOTHERAPEUTICS PLC: profit or loss including noncontrolling interests
- BARINTHUS BIOTHERAPEUTICS PLC: comprehensive income or loss
- BARINTHUS BIOTHERAPEUTICS PLC: general and administrative expense
- BARINTHUS BIOTHERAPEUTICS PLC: depreciation expense
- BARINTHUS BIOTHERAPEUTICS PLC: depreciation, depletion and amortization
- BARINTHUS BIOTHERAPEUTICS PLC: amortization of intangible assets
- BARINTHUS BIOTHERAPEUTICS PLC: nonoperating interest expense
- BARINTHUS BIOTHERAPEUTICS PLC: other nonoperating income or expense
- BARINTHUS BIOTHERAPEUTICS PLC: nonoperating income or expense
- BARINTHUS BIOTHERAPEUTICS PLC: deferred income tax expense or benefit
- BARINTHUS BIOTHERAPEUTICS PLC: income taxes paid, net
- BARINTHUS BIOTHERAPEUTICS PLC: proceeds from issuing common stock
- BARINTHUS BIOTHERAPEUTICS PLC: operating lease payments
- BARINTHUS BIOTHERAPEUTICS PLC: change in accounts receivable
- BARINTHUS BIOTHERAPEUTICS PLC: change in accounts payable
Inspect the source
- Entity
- BARINTHUS BIOTHERAPEUTICS PLC / CIK 0001828185
- Captured
- 2026-09-21T17:29:52.050Z
- SEC response SHA-256
8d55f21db544ef520bf8da480a7de13c67a963dcccd78044df65f40206ee3efc
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001828185.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))